sr 48692 has been researched along with fluphenazine in 1 studies
Studies (sr 48692) | Trials (sr 48692) | Recent Studies (post-2010) (sr 48692) | Studies (fluphenazine) | Trials (fluphenazine) | Recent Studies (post-2010) (fluphenazine) |
---|---|---|---|---|---|
203 | 3 | 36 | 2,494 | 400 | 130 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McCormick, SE; Stoessl, AJ | 1 |
1 other study(ies) available for sr 48692 and fluphenazine
Article | Year |
---|---|
Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia.
Topics: Animals; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Fluphenazine; Globus Pallidus; Male; Mastication; Prodrugs; Pyrazoles; Quinolines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Stereotyped Behavior; Substantia Nigra | 2003 |